20 October, 03:19
#Phispers Week 41 - Weekly Pharma News Recap
Bonjour,
- FDA publishes GDUFA III user fees, increases ANDA, DMF fees.
- Merck’s cardiovascular disease drug succeeds in late-stage trial, validates US$ 11.5 bn Acceleron buyout.
- FDA grants fast-track status to Lilly’s diabetes drug Mounjaro to treat obesity.
- Bayer’s Vividion signs potential US$ 930 million oncology deal with Tavros.
- GSK’s Boostrix vaccine gets add-on approval to prevent whooping cough in infants.
- Sanofi, Regeneron flaunt Dupixent’s benefit in eosinophilic esophagitis trial in kids.
- Two-year data on Roche’s Evrysdi shows benefit in spinal muscular atrophy.
- US ADHD drug crisis deepens as Novartis’ Sandoz also reports shortage of Adderall.
- EDQM finds one major deficiency at Biocon’s API facility in Bengaluru.
#Phispers This Week - PharmaCompass.com's Weekly News Recap
#Healthcare #pharmaceuticals #pharmanews #pharmaceuticalindustry
https://lnkd.in/dE5X4qag
Bonjour,
- FDA publishes GDUFA III user fees, increases ANDA, DMF fees.
- Merck’s cardiovascular disease drug succeeds in late-stage trial, validates US$ 11.5 bn Acceleron buyout.
- FDA grants fast-track status to Lilly’s diabetes drug Mounjaro to treat obesity.
- Bayer’s Vividion signs potential US$ 930 million oncology deal with Tavros.
- GSK’s Boostrix vaccine gets add-on approval to prevent whooping cough in infants.
- Sanofi, Regeneron flaunt Dupixent’s benefit in eosinophilic esophagitis trial in kids.
- Two-year data on Roche’s Evrysdi shows benefit in spinal muscular atrophy.
- US ADHD drug crisis deepens as Novartis’ Sandoz also reports shortage of Adderall.
- EDQM finds one major deficiency at Biocon’s API facility in Bengaluru.
#Phispers This Week - PharmaCompass.com's Weekly News Recap
#Healthcare #pharmaceuticals #pharmanews #pharmaceuticalindustry
https://lnkd.in/dE5X4qag
FDA steps up user fee under GDUFA III; Merck’s heart drug succeeds in late-stage study | Radio Compass Phisper
On September 30, the US President Joe Biden had signed into law the Food and Drug Administration Reauthorization Act (FDARA), which includes the reauthorization of the Generic Drug User Fee Amendments (GDUFA) through September 2027. In this week’s Phispers, we bring you the new GDUFA III fe...
https://lnkd.in/dE5X4qag
19 October, 03:37
𝙁𝙪𝙩𝙪𝙧𝙚 𝙤𝙛 𝙩𝙝𝙚 #Contract Research Organization (CRO) Services_𝙄𝙣𝙙𝙪𝙨𝙩𝙧𝙮
𝙇𝙖𝙩𝙚𝙨𝙩 𝙄𝙣𝙙𝙪𝙨𝙩𝙧𝙮 𝙍𝙚𝙨𝙚𝙖𝙧𝙘𝙝 𝙋𝘿𝙁, 𝙍𝙚𝙦𝙪𝙚𝙨𝙩 𝙃𝙚𝙧𝙚- https://lnkd.in/eR2nC5Us
The #CRO services market size is projected to reach USD 90,926.3 Million by the end of 2026, exhibiting a CAGR of 11.4% in the forecast period (2019-2026). However, the market was worth USD 38,396.4 Million in 2018.
North America to Dominate: Increasing Research & Development Activities to Favor Growth
The market can be geographically categorized into Latin America, Europe, North America, the Middle East and Africa, and Asia Pacific. Amongst them, North America will be in the dominant position during the forthcoming years.
#radiology #opportunities #surveillance #tech #futureofwork #Healthcare #pharmaceutical #research #pharmaceuticals #economy #greentech #growth #business #medicine #hospital #data #telemedicine #telemedicina #opentowork #onlineconsultation #Startup #StartupFunding #medicaldevices #medicalequipment #medical #usa #europe #london #canada #france #statistics #investment #australia #health #environment #compliance #Healthcare #development #africa #middleeast #latinamerica #asiapacific #medicalsciences #jointreplacement #
𝙇𝙖𝙩𝙚𝙨𝙩 𝙄𝙣𝙙𝙪𝙨𝙩𝙧𝙮 𝙍𝙚𝙨𝙚𝙖𝙧𝙘𝙝 𝙋𝘿𝙁, 𝙍𝙚𝙦𝙪𝙚𝙨𝙩 𝙃𝙚𝙧𝙚- https://lnkd.in/eR2nC5Us
The #CRO services market size is projected to reach USD 90,926.3 Million by the end of 2026, exhibiting a CAGR of 11.4% in the forecast period (2019-2026). However, the market was worth USD 38,396.4 Million in 2018.
North America to Dominate: Increasing Research & Development Activities to Favor Growth
The market can be geographically categorized into Latin America, Europe, North America, the Middle East and Africa, and Asia Pacific. Amongst them, North America will be in the dominant position during the forthcoming years.
#radiology #opportunities #surveillance #tech #futureofwork #Healthcare #pharmaceutical #research #pharmaceuticals #economy #greentech #growth #business #medicine #hospital #data #telemedicine #telemedicina #opentowork #onlineconsultation #Startup #StartupFunding #medicaldevices #medicalequipment #medical #usa #europe #london #canada #france #statistics #investment #australia #health #environment #compliance #Healthcare #development #africa #middleeast #latinamerica #asiapacific #medicalsciences #jointreplacement #
Request Sample PDF - CRO Services Market Worth $163.48 Bn by 2029 | 12.1% CAGR
The global CRO services market is projected to grow from $73.38 billion in 2022 to $163.48 billion by 2029, at a CAGR of 12.1% in forecast period, 2022-2029
https://lnkd.in/eR2nC5Us
